Stablecoin Development Corp. Files 8-K on Financials
Ticker: NBY · Form: 8-K · Filed: 2026-04-06T08:43:06-04:00
Sentiment: neutral
Topics: financial-results, 8-k, disclosure
TL;DR
Stablecoin Development Corp. dropped its 8-K with financial results on 4/6/2026.
AI Summary
Stablecoin Development Corp. filed an 8-K on April 6, 2026, reporting results of operations and financial condition. The filing includes financial statements and exhibits, with the primary document being the 8-K itself, filed in iXBRL format.
Why It Matters
This 8-K filing provides investors with updated financial information and operational results for Stablecoin Development Corp., crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial results and does not inherently present new risks.
Key Numbers
- 0001389545 — CIK Number (Identifies Stablecoin Development Corp. in SEC filings.)
- 2026-04-06 — Filing Date (Date the 8-K was accepted by the SEC.)
Key Players & Entities
- Stablecoin Development Corp. (company) — Filer of the 8-K
- 0001389545 (company) — CIK number for Stablecoin Development Corp.
- 2026-04-06 (date) — Filing date of the 8-K
FAQ
What specific financial results are detailed in the 8-K filing?
The filing indicates Item 2.02: Results of Operations and Financial Condition, suggesting financial performance details are included, though specific figures are not in the provided text.
What is the primary purpose of this 8-K filing?
The primary purpose is to report the Results of Operations and Financial Condition of Stablecoin Development Corp., as indicated by Item 2.02.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-06 at 08:43:06.
What are the SIC and industry classification for Stablecoin Development Corp.?
The SIC code is 2834 for Pharmaceutical Preparations, and the CF Office classification is 03 Life Sciences.
Where is Stablecoin Development Corp. located?
The company's mailing and business address is 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608.
From the Filing
EDGAR Filing Documents for 0001437749-26-011312 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001437749-26-011312 Filing Date 2026-04-06 Accepted 2026-04-06 08:43:06 Documents 13 Period of Report 2026-04-06 Items Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K nby20260402_8k.htm iXBRL 8-K 32014 2 EXHIBIT 99.1 ex_941501.htm EX-99.1 13494 Complete submission text file 0001437749-26-011312.txt 184403 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA sdev-20260406.xsd EX-101.SCH 3579 4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdev-20260406_def.xml EX-101.DEF 11864 5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdev-20260406_lab.xml EX-101.LAB 15972 6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdev-20260406_pre.xml EX-101.PRE 12079 16 EXTRACTED XBRL INSTANCE DOCUMENT nby20260402_8k_htm.xml XML 3027 Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800 Stablecoin Development Corp (Filer) CIK : 0001389545 (see all company filings) EIN. : 680454536 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 26839684 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)